Health Canada Approves Seegene's Multiplex Respiratory Virus Tests | GenomeWeb
NEW YORK (GenomeWeb News) – Seegene said today that Health Canada has approved two of its multiplex diagnostic tests for respiratory infections.
 
Health Canada awarded Medical Device Licenses for the company’s PCR-based Seeplex RV5 Auto Capillary Electrophoresis Screening and RV12 Auto Capillary Electrophoresis Detection tests.
 
The Seeplex RV5 test detects influenza A, influenza B, and respiratory syncytial virus A/B, and screens for 11 viruses; while the RV12 test identifies 12 viruses individually.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.